EE3 Cost Effectiveness Model on Four Preventive Treatment for Clostridioides Difficile Infection Recurrence From a US Payer Perspective
Jun 1, 2024, 00:00 AM
10.1016/j.jval.2024.03.304
https://www.valueinhealthjournal.com/article/S1098-3015(24)00419-4/fulltext
Section Title :
Section Order :
11649
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00419-4&doi=10.1016/j.jval.2024.03.304